Search Results - Dambkowski, Carl L.

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia

    Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia by Hartley, Iris R., Roszko, Kelly L., Li, Xiaobai, Pozo, Karen, Streit, Jamie, Rivero, Jaydira, Magone, M. Teresa, Smith, Michaele R., Vold, Roo, Dambkowski, Carl L., Collins, Michael T., Gafni, Rachel I.

    Published in JBMR plus
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell‐free DNA results

    Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell‐free DNA results by Pal, Sumanta K., Bajorin, Dean, Dizman, Nazli, Hoffman‐Censits, Jean, Quinn, David I., Petrylak, Daniel P., Galsky, Matthew D., Vaishampayan, Ulka, De Giorgi, Ugo, Gupta, Sumati, Burris, Howard A., Soifer, Harris S., Li, Gary, Wang, Hao, Dambkowski, Carl L., Moran, Susan, Daneshmand, Siamak, Rosenberg, Jonathan E.

    Published in Cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Abstract 2940: Molecular tumor profiling identifies actionable targets in patients with cholangiocarcinoma

    Abstract 2940: Molecular tumor profiling identifies actionable targets in patients with cholangiocarcinoma by Avogadri-Connors, Francesca, Wei, Ge, Dambkowski, Carl L., Li, Gary, Soifer, Harris S.

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    SUN-087 FGFR-Selective Tyrosine Kinase Inhibitors, Such as Infigratinib, Show Potency and Selectivity for FGFR3 at Pharmacologically Relevant Doses for the Potential Treatment of Achondroplasia

    SUN-087 FGFR-Selective Tyrosine Kinase Inhibitors, Such as Infigratinib, Show Potency and Selectivity for FGFR3 at Pharmacologically Relevant Doses for the Potential Treatment of A... by Dobscha, Katherine, Wei, Ge, Dambkowski, Carl L, Rogoff, Daniela

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Infigratinib in Children With Achondroplasia (ACH): Design of PROPEL2 - A Phase 2, Open-Label, Dose-Escalation and Dose-Expansion Study

    Infigratinib in Children With Achondroplasia (ACH): Design of PROPEL2 - A Phase 2, Open-Label, Dose-Escalation and Dose-Expansion Study by Savarirayan, Ravi, Kannu, Peter, Dambkowski, Carl L, Rogoff, Daniela, Irving, Melita

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    SUN-101 Support for a New Therapeutic Approach of Using a Low-Dose FGFR Tyrosine Kinase Inhibitor (Infigratinib) for Achondroplasia

    SUN-101 Support for a New Therapeutic Approach of Using a Low-Dose FGFR Tyrosine Kinase Inhibitor (Infigratinib) for Achondroplasia by Demuynck, Benoit, Filipo, Justine, Li, Gary, Dambkowski, Carl L, Legeai-Mallet, Laurence

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    SUN-093 Prospective Clinical Assessment Study in Children with Achondroplasia: The PROPEL Trial

    SUN-093 Prospective Clinical Assessment Study in Children with Achondroplasia: The PROPEL Trial by Savarirayan, Ravi, Kannu, Peter, Dambkowski, Carl L, Rogoff, Daniela, Irving, Melita

    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Abstract 2220: Fast Versus Slow Recoverers Following Acute Ischemic Stroke

    Abstract 2220: Fast Versus Slow Recoverers Following Acute Ischemic Stroke by Minzer, Brandon M, Dambkowski, Carl L, Schweber, Adam B, Lazar, Ronald M, Marshall, Randolph S

    Published in Stroke (1970)
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: